Green Bay Packers head coach Matt LaFleur commented Tuesday on the possibility of former Packers quarterback Aaron Rodgers signing with the NFC North rival Minnesota Vikings in free agency.

The Minnesota Vikings had a phenomenal 2024 regular season. The Vikings made the playoffs after stellar performances from Sam Darnold, Justin Jefferson and their lockdown defense. However ...

But it turned out to be a Viking Age iron arm bracelet that could be more than 1,000 years old. After the anonymous man discovered the artifact, he contacted a local archaeologist, who advised him ...

Speaking Friday on her Scoop City podcast, Dianna Russini of The Athletic said those she has spoken to believe Rodgers' preference is to sign with the Minnesota Vikings. Rodgers built a Hall of ...

According to multiple NFL insiders, free-agent quarterback Aaron Rodgers wanted the Minnesota Vikings but they didn’t want him. Though the Vikings haven’t expressly told J.J. McCarthy he’s ...

The 44-year-old mogul has revealed Parívie will arrive this spring. By Danielle Directo-Meston E-Commerce Writer If you purchase an independently reviewed product or service through a link on our ...

Witness our Viking adventurer as we dive headfirst into our first thrilling siege, battling for glory and honor! 🔥 With breathtaking landscapes, fierce enemies, and unique gameplay mechanics ...

Finally, there’s some subtext about what transpired between free-agent quarterback Aaron Rodgers and the Minnesota Vikings. And it lends an outline to what’s unfolding right now — from ...

Last year, the Vikings famously crushed their preseason Vegas win total to an extent that few teams in NFL history can match. They came into the year projected to win 6.5 games and more than ...

We may earn a commission from links on this page. Ubsioft will spin off its most successful game franchises, including Assassin’s Creed, Far Cry, and Rainbow Six Siege, into a separate ...

We look forward to reporting data from this trial in the second half of 2025." Viking previously reported positive results from a 28-day Phase 1 multiple ascending dose (MAD) clinical trial of the ...